The global hernia repair market is expected to reach USD 6.60 billion by 2024. Rigorous research & development activities, growing number of obese patients and high susceptibility of geriatric patients to suffer from hernia are expected to drive the market over the forecast period. Increasing technological sophistication in repair devices and rigorous research and development of the drug-eluting mesh is projected to boost the demand for hernia repair devices and consumables.

Post-operative pain is growing concern post-repair with synthetic mesh. Though the cause of pain varies from patient to patient, a primary reason for pain is inflammation associated with the synthetic mesh. Other chronic illnesses related to the use of implanted mesh are abdominal pain, infection (sepsis), bowel obstruction and adhesion. In spite of increasing technological sophistication in mesh technology, synthetic materials remain the most widely used mesh products for hernia repair especially the polypropylene mesh due to their low cost and easy availability.

The biological mesh is gaining momentum in developed countries especially in the U.S. Biologic mesh development has overcome the problem associated the synthetic mesh including foreign body interaction, chronic inflammation, infection, and stiffness. Presence of favorable reimbursement policies coupled with the well-regulated healthcare insurance and increasing prevalence of an inguinal and ventral hernia in developed economies have rendered increased acceptance of this product.

The above mentioned factors collectively boost demand for overall hernia repair consumables and surgical devices market over the forecast period. Owing to shortcomings of synthetic mesh, manufacturers are working on developing cost-effective and technological advanced mesh. For instance, Ariste Medical is developing drug-eluting mesh. These repair products are anticipated to improve the patient outcomes specifically in vascular procedures including hernia and peripheral bypass hemodialysis processes.

Also, manufacturers are focusing on developing composite or hybrid mesh. The hybrid mesh is a result of the combination of best features of biologic and synthetic mesh. Mesh that combines a minute quantity of synthetic material such as polypropylene and biologic building blocks derived from animal tissue has the property to diminish the hazards of inflammatory reactions along with providing long-term durability. Medtronic and COOK Medical are investing in the development of cost-effective composite mesh. This product may overcome the disadvantages associated with the synthetic mesh such as inflammation, sepsis and abdominal adhesion. These factors render cost advantage over the biologic mesh, which in turn is expected to boost the hernia repair market.

Bioelectronics and Biosensors Market - Global bioelectronics and biosensors market was estimated at USD 11.4 billion in 2013. The market is anticipated to grow at a healthy CAGR over 10%, exceeding USD 28 billion from 2016 to 2024.

Home Infusion Therapy Market - Global infusion therapy market was valued at USD 13.0 billion in 2015. Infusion therapy is the procedure usually performed when oral medication treatments are not effective in the patients.

Gynecological Devices Market - The global gynecological devices market is expected to grow at a significant rate during the forecast period owing to the changing lifestyle with more emphasis on health.

Hexa Research has segmented the global hernia repair market based on product, procedure, and region:

Segmentation by product, 2014 - 2024 (USD Million)

• Consumables

• Synthetic Mesh

• Biologic Mesh

• Surgical Devices

Segmentation by procedure, 2014 - 2024 (USD Million)

• Tension Free

• Open Hernia Repair

• Laparoscopic

Segmentation by region, 2014 - 2024 (USD Million)

• North America

• U.S.

• Europe

• Germany

• Asia Pacific

• China

• Central & South America

• Brazil

• Middle East & Africa

• UAE

Key players analyzed:

• Ethicon, Inc.

• Medtronic

• C. R. Bard

• Atrium

About Hexa Research

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.